International Journal of Gynecological Cancer
| 短名 | Int J Gynecol Cancer |
| Journal Impact | 4.22 |
| 国际分区 | ONCOLOGY(Q2) |
| 期刊索引 | SCI Q1中科院 2 区 |
| ISSN | 1048-891X, 1525-1438 |
| h-index | 101 |
| 国内分区 | 医学(2区)医学妇产科学(3区)医学肿瘤学(3区) |
The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.
期刊主页投稿网址| 涉及主题 | 医学生物内科学遗传学癌症病理外科肿瘤科放射科妇科化学卵巢癌免疫学生物化学地质学古生物学宫颈癌数学阶段（地层学）化疗 |
| 出版信息 | 出版商: BMJ Publishing Group，出版周期: Monthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1991，原创研究文献占比: 73.28%，自引率:7.30%， Gold OA占比: 12.90% |
| 平均审稿周期 | 网友分享经验：一般,3-6周 |
| 平均录用比例 | 网友分享经验：容易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
A randomized controlled trial on the oncologic outcomes of use of the intrauterine manipulator in the treatment of apparent uterine-confined endometrial carcinoma: the MANEC Trial
2024-9-11
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study
2024-9-7
Novel scoring system incorporating lipoproteins to predict outcomes of epithelial ovarian cancer patients
2024-9-7
Effects of a combined exercise and dietary intervention on clinical outcomes in patients with ovarian cancer: the Physical Activity and Dietary intervention in OVArian cancer (PADOVA) randomized controlled trial
2024-9-7
Response to: Correspondence on ‘Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial’ by Aznar et al
2024-9-7
Lymphovascular space invasion in node-negative endometrial cancer: what was old is new again
2024-9-7
Oncovascular surgery in gynecologic oncology: en bloc metastatic lymph node and infiltrated inferior vena cava resection followed by patch reconstruction
2024-9-7
Correspondence on ‘Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial’ by Bogani et al
2024-9-7
Implementation of point-of-care cytology for the triage of human papillomavirus-positive women in Cameroon
2024-9-5
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial
2024-9-4
Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer
2024-9-4
Anastomotic diversion rates following integration of indocyanine green fluorescence angiography in cytoreductive surgery for ovarian cancer
2024-9-4
Link between isolated para-aortic lymph node metastasis and intrauterine cancer site in early stage endometrial cancer
2024-9-4
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population
2024-9-3
Fertility outcomes in stage I ovarian immature teratomas
2024-9-1
Treatment of recurrent serous borderline tumors with noninvasive peritoneal implants
2024-9-1
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom
2024-9-1
Lymphnodal recurrences in ovarian cancer: safe techniques in the minimally invasive approach
2024-8-30
Diagnostic management of endometrial cancer in a single horn of a bicornuate uterus
2024-8-30
Video-endoscopic inguinal sentinel lymph node biopsy with indocyanine green in vulvar cancer
2024-8-28
Molecular biology as a driver in therapeutic choices for ovarian cancer
2024-8-28
Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial
2024-8-28
Long-term survival in patients with para-aortic metastatic cervical cancer receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a single-center experience
2024-8-28
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
2024-8-24
Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews
2024-8-24
Advanced cytoreductive procedures: patient positioning and exposition maneuvers in 10 steps
2024-8-22
Enhancing patient care in low-volume practice settings: the crucial role of overseas sub-specialty training
2024-8-21
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe
2024-8-20
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)
2024-8-20
Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation
2024-8-19
Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping
2024-8-19
Correspondence on ‘Cardiophrenic and costophrenic lymphadenectomy in advanced ovarian cancer by prediaphragmatic subxiphoid approach: PS technique’ by Stanciu
2024-8-17
Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study
2024-8-17
SENECA study: staging endometrial cancer based on molecular classification
2024-8-17
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
2024-8-13
Avoidable admissions after minimally invasive hysterectomy
2024-8-9
Efficacy of locoregional analgesic techniques after laparotomy for gynecologic cancer: a systematic review
2024-8-9
Pocket reference based on the International Federation of Gynecology and Obstetrics (FIGO) staging of endometrial cancer 2023
2024-8-7
Navigating the complexities of artificial intelligence in scientific writing: a dual perspective
2024-8-7
Response to: Correspondence on 'Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements' by Kwong et al
2024-8-7
Sentinel node mapping decreases the risk of failed detection of isolated positive para-aortic lymph node in endometrial cancer
2024-8-7
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy
2024-8-7
Intercultural dialogues and multilevel strategies for cervical cancer prevention for the Arhuacos indigenous community in Colombia
2024-8-7
Correspondence on 'Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements' by Fischerova et al
2024-8-7
Cervical cancer: a new era
2024-8-7
Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
2024-8-6
Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis
2024-8-6
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis
2024-8-5
Liver mobilization and sub-diaphragmatic peritonectomy by laparoscopy
2024-8-5
Total pelvic exenteration with radical vulvectomy and anorectal resection in 10 steps
2024-8-5
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远